Have I missed something? The Independent website quotes campaigners warning that hundreds of thousands of dementia sufferers risk missing "life-changing" treatment after diagnosis rates plummeted during the pandemic.
Can you post a link @AgzyHave I missed something? The Independent website quotes campaigners warning that hundreds of thousands of dementia sufferers risk missing "life-changing" treatment after diagnosis rates plummeted during the pandemic.
Is this it?Can you post a link @Agzy
Not just availabilty but cost. Even assuming these drugs are given the OK in this country, who will get them? I can't see the NHS forking out. And the cost is not limited to the drug itself as it has to be given fortnightly, intravenously, i.e. in a hospital setting, which obviously has costs for the NHS. The side effects are serious - brain bleeds, etc. And guess what - anyone on the drug must have regular (very expensive) scans to check for that so there's another cost. And an appropriate consultant to oversee all this.Lecanemab and Aducanumab despite a lot of heralding of these new drugs, they are still very limited in their affect and under development. Availability still has a big question mark over it currently. They might be a scientific breakthrough but my impression is that there is still much work to be done in terms of efficacy.
I think it would be best if you put these points in a letter to the Secretary of State for Health and Social Care, because penultimately only they can answer the question on cost.Not just availabilty but cost. Even assuming these drugs are given the OK in this country, who will get them? I can't see the NHS forking out. And the cost is not limited to the drug itself as it has to be given fortnightly, intravenously, i.e. in a hospital setting, which obviously has costs for the NHS. The side effects are serious - brain bleeds, etc. And guess what - anyone on the drug must have regular (very expensive) scans to check for that so there's another cost. And an appropriate consultant to oversee all this.
How many carers will want to take their PWD to hospital for this treatment every couple of weeks, plus all the necessary checks as well? How many would find it impossible or just too upsetting for their loved one?
Of course, as we don't diagnose people with early dementia, for whom these drugs may have some benefit, the actual cost will be nil. It's just never going to happen...
I also think they are barking up the wrong tree with immunotherapy. At best it seems a rather poor sticking plaster that has a tendency to fall off.The bigger question in the scheme of things is 'does immunotherapy have a real future in the treatment of dementia?' Because so far I haven't seen anything to suggest this, either historically or scientifically convincing research that makes me think 'yes this is it'
Its a very tall order to expect to find a way out for people with dementia with such a small breakthrough, not only that the original news article sings out a type of single treatment for dementia, which of course is another untruth because there can never be a single treatment for all types of dementia.I also think they are barking up the wrong tree with immunotherapy. At best it seems a rather poor sticking plaster that has a tendency to fall off.
This is key. And perhaps we need to follow up with the research that discovered dementia starts 15 years+ before symptoms appear. Surely that would seem to be a better starting point.Screening needs to start much earlier
I think with early onset dementia and I mean in people who are in their 30's there is a good enough argument to say that old age is not a sufficient marker of dementia, even though it seems to be diagnosed in later ages and perhaps for all intents and purposes there is a missing link. The problem with researchers is that they have to narrow their research questions and designs to prove a specific aspect and whilst this may or may not be productive it means there are gaps elsewhere that are unexplored until someone says hey look over here instead of over there -that process amongst researchers can take decadesWe have screening for all sorts of diseases, in some cases quite frequent screening, and so you could screen for dementia at, say, 55 or 60 years of age. Treatments are only likely to be effective if they are started early. I think that dementia is still seen as a disease that affects old people but these days people in their later 60s and 70s - the classic ages at which people with dementia show symptoms (of course, some people show symptoms much later) - are not considered old and are regarded as having many years of at least a reasonable quality of life left.
Sometimes we just have to laugh at the face of adversity and think something I can't repeat on here 😁And yet… only a couple of weeks ago, some newspaper (sorry, can’t remember which one) was heralding the news that the new initiative to pick up potential cases of dementia was to screen care home residents. Now, as we all know, 70% of care home residents are only there because their dementia is so advanced that they have to be. So what nut job thought this up? And what does it say about the complete lack of understanding there continues to be about absolutely everything connected to dementia? I despair, I really do.
It was just this quote on my ipad and Goggle showing snippets from newspaper headlines and this was from ‘The Independent’ and it annoys me as these throwaway headlines raise hopes that will be dashed. Proved and excellent response rom you and other though, thank you xCan you post a link @Agzy
I don’t think that in spite of years of research, there is enough known about dementia. You only have to read the posts on TP to know that there is a great diversity and variability in the expression of dementia in the people we care for which indicates to me that we are still in the realms of comparative ignorance when it comes to these diseases.Currently there is only one new drug that has been developed so I am not quite sure how significant this statement is as reported :
“At a time when new treatments for dementia are on the horizon, it has never been more important for people to be diagnosed quickly and accurately. Failure to improve diagnosis rates could result in many people missing out on potentially life-changing medicines when they are available.”Note it states 'potentially life-changing medicines when available' -referring to the new immunotherapy drugs
Lecanemab and Aducanumab despite a lot of heralding of these new drugs, they are still very limited in their affect and under development. Availability still has a big question mark over it currently. They might be a scientific breakthrough but my impression is that there is still much work to be done in terms of efficacy.
I fail to understand how we have ended up with shortfalls in dementia diagnosis, knowing that early basic interventions can stem off or slow down progression and buy some time. I get very frustrated by the attitude and approach to dementia in my own world of work so it doesn't surprise me that the cultural inheritance dementia has still remains in many quarters. Don't take this the wrong way, but even if someone has a bad cancer prognosis they are more likely to get the right attention, at the right time and in the right place by the right people, but dementia - you might as well bang your head against a brick wall -in fact I think I have on a number of occasions 🤕
Of course pinning this down to its root cause will be difficult. Yes the pandemic was an issue, but should services have been closed down to the extent they were, knowing the impact this would have?
Again people with dementia and their families get a raw deal, but after so long living with this now, nothing surprises me anymore.
I sincerely hope a one point test could be developed, it would save a lot of wasted time.I think it's always going to be very difficult to diagnose early if GPs just use the MMSE. I agree @Lawson58 we need better diagnostic tools - something along the lines of a simple yes/no blood test. If only we could find something specific in the blood that meant you were definitely going to get dementia and was measurable by the age of 30! Maybe then we'd have a chance at treating it effectively.
But I'm thinking that's unlikely. It might be possible for Alzheimer's or some hereditary dementias but things like vascular dementia often develop only after a stroke and who knows who is going to have a stroke? For that we can only go on all the usual things we're supposed to do to prevent (lessen the chance of) strokes. So it's back to healthy diet and exercise, no smoking, etc. But that is not an answer! If anything, it draws us away from looking for the origins of dementia in the brain and I really think that's where we should be looking.
If I decide to put my billions of spare cash into research/pharmaceuticals, that's the direction I would go. I would not be looking for drugs to 'treat' dementia once it is very apparent because I don't really think that is possible. I'd love to be wrong.